- Generic name
- Pregabalin
- Strength
- 82.5 mg
- Dosage form
- Cr Tablet
- Manufactured by
- Delta Pharma Limited
Lyca 82.5 CR Cr Tablet
About Lyca 82.5 CR Cr Tablet
Lyca 82.5 CR is a cr tablet from Delta Pharma Limited, with the generic name Pregabalin. This includes nerve pain from diabetes (diabetic peripheral neuropathy) and from shingles (postherpetic neuralgia).
There are 105 brands of Pregabalin listed in Bangladesh. The lowest listed price is GAPA-P 150 mg Capsule at ৳ 1 per unit.
What is Lyca 82.5 CR Cr Tablet?
The cr tablet Lyca 82.5 CR contains Pregabalin and is made by Delta Pharma Limited. Lyca 82.5 CR is available only with a doctor's prescription. It is a prescription medicine, so the doctor decides whether it suits you and how it should be taken. The dose and length of treatment are set by the doctor, not by the patient.
Uses of Lyca 82.5 CR
This includes nerve pain from diabetes (diabetic peripheral neuropathy) and from shingles (postherpetic neuralgia). Lyca 82.5 CR is used for nerve pain associated with diabetic peripheral neuropathy and postherpetic neuralgia, for fibromyalgia, and for nerve pain linked to spinal cord injury in adults. This medicine is an adjunct anti-epileptic drug. Your doctor will confirm whether it is appropriate for your condition and will explain the treatment plan.
How to use Lyca 82.5 CR
Do not crush or chew it unless your doctor says so, because that can change how the medicine is released. Lyca 82.5 CR is taken by mouth. Swallow the cr tablet with water. Take Lyca 82.5 CR 82.5 mg cr tablet exactly as prescribed by your doctor. Do not stop suddenly on your own, as this can cause problems; your doctor will guide any change. If you miss a dose, ask your pharmacist or doctor what to do.
Side effects of Lyca 82.5 CR
The doctor or pharmacist can advise on what to watch for. If you experience any side effect, especially if it bothers you or does not go away, tell your doctor or pharmacist. Common side effects reported with Pregabalin include dizziness, sleepiness, dry mouth, swelling, blurred vision, weight gain and difficulty concentrating.
Safety and precautions
Small amounts pass into breast milk, and breastfeeding is not recommended during treatment because of a potential risk of tumour growth. Do not use Lyca 82.5 CRe if you are allergic to Pregabalin or any ingredient. Ask the doctor before use if pregnant, planning pregnancy or breastfeeding. Ask your doctor first if any of these apply to you.
Frequently asked questions
What does Lyca 82.5 CR treat?
This includes nerve pain from diabetes (diabetic peripheral neuropathy) and from shingles (postherpetic neuralgia). Lyca 82.5 CR is used for nerve pain associated with diabetic peripheral neuropathy and postherpetic neuralgia, for fibromyalgia, and for nerve pain linked to spinal cord injury in adults.
How do I use Lyca 82.5 CR correctly?
Do not crush or chew it unless your doctor says so, because that can change how the medicine is released. Lyca 82.5 CR is taken by mouth.
Can Lyca 82.5 CR cause side effects?
The doctor or pharmacist can advise on what to watch for. If you experience any side effect, especially if it bothers you or does not go away, tell your doctor or pharmacist.
Is Lyca 82.5 CR safe for everyone?
Small amounts pass into breast milk, and breastfeeding is not recommended during treatment because of a potential risk of tumour growth. Do not use Lyca 82.5 CRe if you are allergic to Pregabalin or any ingredient.
Indications
- Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
- Postherpetic neuralgia (PHN)
- Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
- Fibromyalgia
- Neuropathic pain associated with spinal cord injury ... Read more
- Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
- Postherpetic neuralgia (PHN)
- Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older
- Fibromyalgia
- Neuropathic pain associated with spinal cord injury
- Neuropathic pain associated with diabetic peripheral neuropathy (DPN)
- Postherpetic neuralgia (PHN)
Pharmacology
Dosage & Administration
Postherpetic neuralgia in adults (PHN): The recommended dose of Pregabalin is 75 to 150 mg two times a day or 50 to 100 mg three times a day (150 to 300 mg/day) in patients with creatinine clearance of at least 60 ml/min. Dosing should begin at 75 mg two times a day or 50 mg three times a day (150 mg/day). The dose may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 300 mg/day and who are able to tolerate Pregabalin, may be treated with up to 300 mg two times a day or 200 mg three times a day (600 mg/day).
Begin dosing of Pregabalin CR capsule at 165 mg once daily and increase to 330 mg once daily within 1 week based on individual patient response and tolerability. Patients who do not experience sufficient pain relief following 2 to 4 weeks of treatment with 330 mg once daily and who are able to tolerate Pregabalin CR capsule, may be treated with up to 660 mg once daily. In view of the dose-dependent adverse reactions and the higher rate of treatment discontinuation due to adverse reactions, dosing above 330 mg/day should be reserved only for those patients who have on-going pain and are tolerating 330 mg daily. The maximum recommended dose of Pregabalin CR capsule is 660 mg once daily.
Management of fibromyalgia in adults: The recommended dose of Pregabalin is 300 to 450 mg/day. Dosing should begin at 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient benefit with 300 mg/day may be further increased to 225 mg two times a day (450 mg/day).
Neuropathic pain associated with spinal cord injury in adults: The recommended dose range of Pregabalin is 150 to 600 mg/day. The recommended starting dose is 75 mg two times a day (150 mg/day). The dose may be increased to 150 mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Patients who do not experience sufficient pain relief after 2 to 3 weeks of treatment with 150 mg two times a day and who tolerate Pregabalin may be treated with up to 300 mg two times a day.
Conversion from Pregabalin capsules to Pregabalin CR capsule tablet: When switching from Pregabalin capsules to Pregabalin CR capsule tablet on the day of the switch, instruct patients to take their morning dose of Pregabalin capsule as prescribed and initiate Pregabalin CR capsule therapy after an evening meal.
Pregabalin tablet total daily dose (dosed 2 or 3 times daily): Pregabalin CR capsule capsule dose (dosed once a day)
- 75 mg/daily: 82.5 mg/day
- 150 mg/daily: 165 mg/day
- 225 mg/daily: 247.5 mg/day
- 300 mg/daily: 330 mg/day
- 450 mg/daily: 495 mg/day
- 600 mg/daily: 660 mg/day
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Overdose Effects
Storage Conditions
Alternative brands of Pregabalin
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.